|
|
Article: Chiron launches Cubicin in EU.(European Union's European Commission approves marketing of intravenous antibiotic)(Brief Article)
- Article from:
- Pharma Marketletter
- Article date:
- January 30, 2006
CopyrightCOPYRIGHT 2006 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The USA's Chiron Corp says that the European Commission has granted marketing approval for Cubicin (daptomycin), a first-in-class intravenous antibiotic. The marketing approval was granted in the 25 member states of the European Union, Iceland, Liechtenstein and Norway. Under the approval, Cubicin is indicated for the treatment of complicated skin and soft-tissue ...